Rituximab induces complete remission in a case of membranous nephropathy associated with hepatitis C virus- related infection.
Pansini
Francesca
F
Bonifati
Carmen
C
Manno
Carlo
C
Schena
Francesco Paolo
FP
D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D015433:Glomerulonephritis, Membranous / Q000150:complications* / Q000188:drug therapy*; D006526:Hepatitis C / Q000150:complications*; D006801:Humans; D008297:Male; D012074:Remission Induction; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab